Welcome to the international HTA database

Showing [23384 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Aripiprazole (Abilify®) tablets for the treatment of moderate to severe manic episodes in Bipolar I Disorder and for the prevention of a new manic episode in patients who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Improving the efficiency and quality of follow-up after curative treatment for breast cancer]
2009	University of York	A systematic review of prognostic serum markers in febrile neutropenic episodes in children and young people undergoing treatment for malignant disease (Protocol for a systematic review)
2009	HAYES, Inc.	Natalizumab (Tysabri, Biogen Idec and Elan Pharmaceuticals) for relapsing remitting multiple sclerosis
2009	Andalusian Health Technology Assessment Area (AETSA)	[The state of research into inequalities in the incidence, death, prevention and healthcare in cancer in Spain. A bibliometric study and literature review.]
2009	Committee for New Health Technology Assessment (CNHTA)	[Extremely low temperature cool chamber]
2009	Agency for Healthcare Research and Quality (AHRQ)	Screening for visual impairment in older adults: systematic review to update the 1996 U.S. Preventive Services Task Force recommendation
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Aliskiren (Rasilez®) for the treatment of essential hypertension
2009	Andalusian Health Technology Assessment Area (AETSA)	[Clinical effectiveness of ozone therapies]
2009	HAYES, Inc.	Percutaneous sacroplasty for treatment of sacral insufficiency fractures
2009	Committee for New Health Technology Assessment (CNHTA)	[The vest airway clearance system]
2009	VA Technology Assessment Program (VATAP)	Quality measures in surgery
2009	Agency for Healthcare Research and Quality (AHRQ)	Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ambrisentan (Volibris®) for pulmonary arterial hypertension
2009	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Non-drug therapies in Alzheimer's disease]
2009	HAYES, Inc.	Mechanical embolus removal device (Merci Retriever) (Concentric Medical Inc.) for ischemic stroke
2009	HAYES, Inc.	Prehospital/emergency department therapeutic hypothermia for out-of-hospital cardiac arrest (OHCA) in adults
2009	Committee for New Health Technology Assessment (CNHTA)	[Percutaneous cement injection plasty of metastatic bone tumor]
2009	Agency for Healthcare Research and Quality (AHRQ)	Screening for child and adolescent depression in primary care settings: a systematic evidence review for the U.S. Preventive Services Task Force
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Eculizumab (Soliris®) for the treatment of paroxysmal nocturnal haemoglobinuria
2009	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Long-acting insulin analogues in the treatment of diabetes mellitus type 2]
2009	HAYES, Inc.	Agento I.C. silver-coated endotracheal tube (C.R. Bard Inc.) for the prevention of ventilator- associated pneumonia (VAP)
2009	HAYES, Inc.	Robotically assisted nephrectomy for renal malignancy using the da Vinci surgical system (Intuitive Surgical Inc.) for adult patients
2009	Committee for New Health Technology Assessment (CNHTA)	[Autologous blood injection]
2009	Agency for Healthcare Research and Quality (AHRQ)	Nutritional research series: advancing the role of evidence-based reviews in nutrition research and applications. Volume 1: application of systematic review methodology to the field of nutrition
2009	Agency for Healthcare Research and Quality (AHRQ)	Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Maraviroc (Celsentri®) for treatment-experienced adults infected only with CCR5-tropic HIV-1
2009	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Clopidogrel plus acetylsalicylic acid in acute coronary syndrome]
2009	HAYES, Inc.	Synvisc (hylan G-F 20) (Genzyme Corp.) for arthritis of the ankle
2009	Committee for New Health Technology Assessment (CNHTA)	[ThinPrep liquid-based aspiration cytopathology test]
2009	Agency for Healthcare Research and Quality (AHRQ)	Nutritional research series: advancing the role of evidence-based reviews in nutrition research and applications Volume 2: issues and challenges in conducting systematic reviews to support development of nutrient reference values: workshop summary
2009	Agency for Healthcare Research and Quality (AHRQ)	Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Anidulafungin (Ecalta®) for the treatment of invasive candidiasis in adult non-neutropenic patients
2009	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Different antihypertensive drugs as first-line therapy in patients with essential hypertension]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[More efficient use of corneal donor donations: the Dutch Lamellar Corneal Transplantation Study (DLCTS-Study)]
2009	Andalusian Health Technology Assessment Area (AETSA)	[Organisational models in caring type 2 diabetes mellitus patients. Literature review and economic assessment]
2009	HAYES, Inc.	Allogeneic stem cell transplantation for chronic lymphocytic leukemia (CLL)
2009	HAYES, Inc.	Mindstreams cognitive health assessment (NeuroTrax Corp.) product suite (U.S - Clinical Edition) for assessing mild cognitive impairment
2009	HAYES, Inc.	Trellis-8 Peripheral Infusion System (Bacchus Vascular Inc.) for deep vein thrombosis
2009	Committee for New Health Technology Assessment (CNHTA)	[JAK2 gene exon 12 mutation analysis]
2009	Agency for Healthcare Research and Quality (AHRQ)	Nutritional research series: advancing the role of evidence-based reviews in nutrition research and applications. Volume 3: reporting of systematic reviews of micronutrients and health: a critical appraisal
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Nelarabine (Atriance®) for the treatment of T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma
2009	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Systematic guideline search and appraisal for the DMP "Obesity"]
2009	Andalusian Health Technology Assessment Area (AETSA)	[Organisational models in caring for patients with cancer]
2009	HAYES, Inc.	Acupuncture for treatment of headache
2009	Committee for New Health Technology Assessment (CNHTA)	[NPM1 gene sequencing analysis]
2009	Agency for Healthcare Research and Quality (AHRQ)	Evaluating test strategies for colorectal cancer screening - age to begin, age to stop, and timing of screening intervals: a decision analysis of colorectal cancer screening for the U.S. Preventive Services Task Force from the Cancer Intervention and Surveillance Modeling Network (CISNET).
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Thalidomide (Thalidomide Pharmion®) in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged GE 65 years or ineligible for high dose chemotherapy
2009	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Interventions in young children with obstructive airway diseases]
2009	Andalusian Health Technology Assessment Area (AETSA)	[Organisational models in palliative care. A comparison on consumption of resources]
2009	Institute for Clinical Effectiveness and Health Policy (IECS)	[Inhaled tobramycin for cystic fibrosis]
2009	HAYES, Inc.	Acupuncture for treatment of postoperative pain
2009	Committee for New Health Technology Assessment (CNHTA)	[High density EEG dipole source localization]
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Efavirenz / emtricitabine / tenofovir disoproxil (as fumarate) (Atripla®) for the treatment of HIV-1 infection in adults
2009	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Positron emission tomography (PET) in malignant lymphoma]
2009	HAYES, Inc.	Antimicrobial central venous catheters
2009	Committee for New Health Technology Assessment (CNHTA)	[Epstein-Barr virus EA IgA]
2009	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Glinides in the treatment of diabetes mellitus type 2]
2009	HAYES, Inc.	Combined positron emission tomography-computed tomography (PET-CT) for lung
2009	Committee for New Health Technology Assessment (CNHTA)	[Epstein-Barr virus VCA IgA]
2009	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Exploration of the topic "Decompression for carpal tunnel syndrome" - Rapid report]
2009	HAYES, Inc.	Antibacterial suture for prevention of infection
2009	HAYES, Inc.	Computer-assisted cognitive-behavioral treatment for depression
2009	Committee for New Health Technology Assessment (CNHTA)	[Intramuscular transplantation of autologous bone marrow stem cell(therapeutic angiogenesis)]
2009	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Exploration of the topic "Conization of the cervix uteri" - Rapid report]
2009	HAYES, Inc.	D-Cycloserine for anxiety disorders
2009	Committee for New Health Technology Assessment (CNHTA)	[Transanal endoscopic microsurgery(TEM)]
2009	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Exploration of the topic "Cataract surgery" -Rapid report]
2009	HAYES, Inc.	Direct brain tissue oxygen monitoring for traumatic brain injury
2009	Committee for New Health Technology Assessment (CNHTA)	[POCT(point of care test) prothrombin time]
2009	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Exploration of the topic "Surgery for varices" - Rapid report]
2009	HAYES, Inc.	Myotonic dystrophy types 1 and 2
2009	HAYES, Inc.	Endovascular repair of abdominal Aortic aneurysms
2009	Committee for New Health Technology Assessment (CNHTA)	[TEL/AML1 rearrangement, quantitative [real-time RT-PCR]]
2009	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Relevance of the condition of the opposite dentition when fitting a fixed or removable denture]
2009	HAYES, Inc.	Epsilon-aminocaproic acid and tranexamic acid for coronary artery bypass graft surgery
2009	Committee for New Health Technology Assessment (CNHTA)	[WT1 gene mRNA, quantitative[real-time RT-PCR]]
2009	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Reduction of salt intake in essential hypertension - Rapid report]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Self-management of asthma supported by hospitals, ICT, nurses and general practitioners]
2009	HAYES, Inc.	Nebulized antibiotic therapy for chronic sinusitis
2009	HAYES, Inc.	Etanercept for ankylosing spondylitis
2009	Committee for New Health Technology Assessment (CNHTA)	[NPM1 mutant mRNA, quantitative [real-time RT-PCR]]
2009	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Selective serotonin and norepinephrine re-uptake inhibitors (SNRI) in the treatment of depression]
2009	VA Technology Assessment Program (VATAP)	Visual problems in traumatic brain injury
2009	HAYES, Inc.	NK pressure-specified sensory device (Sensory Management Services LLC) for tarsal tunnel syndrome diagnosis
2009	HAYES, Inc.	Etanercept for psoriasis and psoriatic arthritis
2009	Belgian Health Care Knowledge Centre (KCE)	Magnetic Resonance Imaging: cost analysis
2009	Committee for New Health Technology Assessment (CNHTA)	[BAALC gene mRNA, quantitative [real-time RT-PCR]]
2009	VA Technology Assessment Program (VATAP)	Complementary and alternative therapies for post-traumatic stress disorder
2009	HAYES, Inc.	High-intensity focused ultrasound treatment for prostate cancer
2009	Committee for New Health Technology Assessment (CNHTA)	[Laparoscopic adjustable gastric banding for morbid obesity]
2009	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Scientific evaluation of different investigational methods used in diagnosing "bronchial asthma" in children aged 2 to 5 years]
2009	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[Screening mammography for woman aged 40-49: update]
2009	HAYES, Inc.	Beds and mattresses designed to prevent pressure ulcers
2009	HAYES, Inc.	NovoSeven Coagulation Factor VIIa (Recombinant) (Novo Nordisk Inc.) for treatment of acute intracerebral hemorrhage
2009	HAYES, Inc.	Spinal muscular atrophy
2009	HAYES, Inc.	Intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis resulting from cancers of the lower gastrointestinal tract
2009	Committee for New Health Technology Assessment (CNHTA)	[Bladder tumor antigen test]
2009	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Screening for defined speech and language development disorders in children]
2009	HAYES, Inc.	NovoSeven Coagulation Factor VIIa (Recombinant) (Novo Nordisk Inc.) for treatment of surgical bleeding